Kasivisvanathan V, et al. - Researchers comparatively scrutinized the multiparametric magnetic resonance imaging (MRI), with or without targeted biopsy vs standard transrectal ultrasonography–guided biopsy for the detection of prostate cancer in men with a raised prostate-specific antigen level who had not undergone biopsy. Findings illustrated the superiority of the use of risk assessment with MRI before biopsy and MRI-targeted biopsy compared to standard transrectal ultrasonography–guided biopsy in men at clinical risk for prostate cancer who had not undergone biopsy previously.